Next, we constructed 15 EpCAM X CLDN3 bsAbs and tested their binding and internalization activity in OVCAR-3 and NCI-H1781 cancer cells to obtain bsAbs that could restore binding and internalization activities (Fig. S2). This evidence concerns the gene CLDN3 and cancer.